IP Library Granted Patent US 6,936,736
Granted Patent B2
US 6,936,736 · App. 10/105,271 · Granted Aug 30, 2005

Amide derivative

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,936,736
App. No.
10/105,271
Granted
Aug 30, 2005
Kind
B2
Abstract

A compound of the formula: wherein Ar is optionally substituted phenyl, etc.; n is 0, 1 or 2; R 1 is hydogen atom, optionally substituted alkyl, etc.; R 2 and R 3 are independently optionally substituted alkyl, etc.; R 4 and R 5 are independently hydrogen atom or optionally substituted alkyl; R 6 is hydrogen atom, hydroxy or alkyl; or a pharmaceutically acceptable salt thereof is useful as a medicament for treating retinal degenerative disorders and the like.

Claims (6)

1. N-t-Butyl-2,4-difluorobenzamide, N-(2-hydroxy-1,1-dimethylethyl)-2,4-difluorobenzamide, or a pharmaceutically acceptable salt thereof.

2. A compound of the formula:

R 1 is methyl, ethyl, hydroxymethyl or hydroxyethyl and both of R 2 and R 3 are methyl,

R 6 is hydrogen atom, hydroxy or alkyl;

or a pharmaceutically acceptable salt thereof.

3. A compound or a pharmaceutically acceptable salt thereof according to claim 2 , wherein R 6 is a hydrogen.

Assignments (1)
MERGER Recorded Dec 16, 2005
From: SUMITOMO PHARMACEUTICALS COMPANY, LTD.
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017089/0420 →